American Board of Pediatrics
Duke University School of Medicine
Naval Medical Center San Diego
Johns Hopkins University
The U.S. Navy brought Dr. Vanscoy to the area in 2010 and she now considers Norfolk her home. During her 20-year Navy career, Dr. Vanscoy cared for children with a wide variety of chronic respiratory diseases including asthma, chronic lung disease, respiratory failure and ventilator-dependence. For six years directed the CF Center at the Naval Medical Center Portsmouth, the largest CF center in the Department of Defense, years and served as the medical director for all six of the military’s CF centers from 2012 to 2016.
She has a special interest in children with complex respiratory and gastroenterology disorders and very strongly believes that these children are best served by a collaborative, multidisciplinary team approach to care. As a mother, Dr. Vanscoy understands just how precious our children are. She is passionate about ensuring children can breathe easily and experience active lives without respiratory limitation.
Dr. Vanscoy is married, has two daughters, and is a swim mom, volunteer, and chauffeur to many music lessons and activities. When she finds a bit of free time, she enjoys reading, cooking, running, and yoga.
Honors and Awards:
Naval Medical Center Portsmouth Master Clinician, 2014
Merck Manual Award for Academic Achievement, Duke University School of Medicine, 1998
Marcia Mitzner Scholarship for Pulmonary Research, Duke University School of Medicine, 1996
David R. Marsh Design Award for best senior design project in Weapons & Systems Engineering, U.S. Naval Academy, 1992
Wright FA, Strug LJ, Doshi VK, Commander CW, Blackman SM, Sun L, Berthiaume T, Cutler D, Cojocaru A, Collaco JM, Corey M, Dorfman R, Goddard K, Green D, Kent JW Jr, Lange EM, Lee S, Li W, Luo J, Mayhew GM, Naughton KM, Pace RG, Pare P, Rommens JM, Sandford A, Stonebraker JR, Sun W, Taylor C, Vanscoy LL, Zou F, Blangero J, Zielenski J, O’Neal WK, Drumm ML, Durie PR, Knowles MR, Cutting GR. “Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nat Genet. Jun 2011. 43(6):539-46.
McDougal KE, Green DM, Vanscoy LL, Fallin MD, Grow M, Cheng S, Blackman SM, Collaco JM, Henderson LB, Naughton K, Cutting GR. Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosis. Eur J Hum Genet. 2010 Jun;18(6):680-4.
Blackman SM, Hsu S, Vanscoy LL, Collaco JM, Ritter SE, Naughton K, Cutting GR. “Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis”. J Clin Endocrinol Metab. Apr 2009. 94(4): 1302-9.
Bremer LA, Blackman SM, Vanscoy LL, McDougal KE, Bowers A, Naughton KM, Cutler DJ, and Cutting GR. “Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis”. Hum Mol Genet. 15 July 2008. 17(14):2228-37.
Collaco JM, Vanscoy L, Bremer L, McDougal K, Blackman SM, Bowers A, Naughton K, Jennings J, Ellen J, and Cutting GR. “Interactions Between Secondhand Smoke and Genes That Affect Cystic Fibrosis”. JAMA 30 January 2008. 299(4):417-424.
Vanscoy LL, Blackman SM, Collaco JM, Bowers A, Lai T, Naughton K, Algire M, McWilliams R, Beck S, Hoover-Fong J, Hamosh A, Cutler D, and Cutting GR. “Heritability of CF Lung Disease Severity”. AJRCCM. 15 May 2007. 175(10):1036-1043.
Vanscoy LL and Laube BL. “The Challenges of Delivery of Aerosolized Medications to Infants and Young Children”. eNeonatal. Vol.2, Issue 3, November 2004.
CHKD Main Hospital
601 Children's Ln
Norfolk, VA 23518
500 Discovery Dr
Chesapeake, VA 23320
Oyster Point Office
11783 Rock Landing Drive
Newport News, VA 23606
Princess Anne Office
2021 Concert Dr
Virginia Beach, VA 23456